4.3 Article

Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0b013e3181f275fd

关键词

antiretroviral; Africa; HIV; loss to follow-up; unstructured treatment interruption

资金

  1. Wellcome Trust, London, United Kingdom
  2. Bill and Melinda Gates foundation
  3. National Institutes of Health through CIPRA [1U19AI53217-01, A1058736-01A1]
  4. Medical Research Council [G0700837] Funding Source: researchfish
  5. MRC [G0700837] Funding Source: UKRI

向作者/读者索取更多资源

Objective: To investigate antiretroviral treatment (ART) interruption in a long-term treatment cohort in South Africa. Methods: All adults accessing ART between 2004 and 2009 were included in this analysis. Defaulting was defined as having stopped all ART drugs for more than 30 days. Treatment interrupters were patients who defaulted and returned to care during the study, whereas loss to follow-up was defined as defaulting and not returning to care. Kaplan-Meier estimates and Poisson regression models were used to analyze rates and determinants of defaulting therapy and of treatment resumption. Results: Overall rate of defaulting treatment was 12.8 per 100 person-years (95% confidence interval: 11.4 to 14.4). Risk factors for defaulting were male gender, high baseline CD4 count, recency of ART initiation, and time on ART. The probability of resuming therapy within 3 years of defaulting therapy was 42% (event rate = 21.4 per 100 person-years). Factors associated with restarting treatment were female gender, older age, and time since defaulting. Conclusions: Defaulting treatment need not be an irreversible event. Interventions to increase retention in care should target men, less immunocompromised patients, and patients during the first 6 months of treatment. Resumption of treatment is most likely within the first year of interrupting therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据